Full-Time
Provides personalized real world evidence for physicians
$150k - $170k/yr
Mid, Senior
No H1B Sponsorship
Remote in USA
Candidates must be currently authorized to work in the United States on a full-time basis. No visa sponsorship is available.
Upload your resume to see how it matches 11 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Atropos Health provides personalized real-world evidence to help physicians make informed clinical decisions. Their main product is a digital consultation service that allows doctors to quickly access and analyze patient data to answer complex medical questions within 24 hours. This service addresses the 'Evidence Gap' in clinical research, which occurs when traditional studies exclude important patient groups. Atropos Health differentiates itself from competitors by utilizing observational research and technology developed at Stanford University, ensuring that their evidence is relevant and applicable to diverse patient populations. The company's goal is to enhance clinical decision-making by providing timely and accurate information to healthcare providers, hospitals, and research institutions through a subscription-based model.
Company Size
51-200
Company Stage
Series B
Total Funding
$47M
Headquarters
Palo Alto, California
Founded
2019
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
401(k) Retirement Plan
Parental Leave
Flexible Work Hours
Remote Work Options
Home Office Stipend
Atropos Unveils Largest De-Identified Patient Data Source, New Tech for Data Security Linkage. by Syed Hamza Sohail 03/19/2025 Leave a Comment. What You Should Know:– Atropos Health, a leader in automating high-quality real-world evidence (RWE), has launched Nodal Patient Deidentification and Query Time Interval Encoding (Nodal Deid) within the GENEVA OS platform for Atropos Evidence Network members.– This advancement allows members to securely enhance patient longitudinal records with deidentified data mapped to the HIPAA safe harbor standard while retaining full control over their data. Linkage occurs only at query time, eliminating the need for data transfers and ensuring source data remains protected.Atropos Health Enhances Real-World Data Utilization with Nodal Deid and GENEVA OS™Atropos Health, developer of GENEVA OS™, is advancing real-world data (RWD) analysis to close evidence gaps in healthcare. By eliminating traditional data duplication and transfer, Nodal Deid enables secure, real-time queries across the Atropos Evidence Network via ChatRWD®, delivering publication-grade insights in minutes. Mortality data from Veritas Data Research is automatically integrated, with quality assessed through Real World Fitness Score® (RWFS).Health systems can bridge data gaps while maintaining full control and generating passive revenue
What You Should Know:– Atropos Health, a pioneer in in translating clinical data into personalized real-world evidence (RWE) and insights, announced its selection by Emory Healthcare, an academic health system in Georgia, to generate evidence from real-world data (RWD) through a new decision-making tool for clinicians.– The tool aims to improve patient outcomes and lower costs through medication solutions.Transforming Healthcare with Real-World Evidence: Atropos Health and Emory CollaborationAtropos Health, the developer of GENEVA OS, is revolutionizing healthcare by delivering rapid, data-driven evidence through a robust network of real-world data. By partnering with healthcare and life sciences organizations, Atropos Health aims to close evidence gaps from bench to bedside, enhance patient outcomes with data-driven care, and expedite groundbreaking research in medicine.Advancing Patient Care Through Data-Driven InsightsRapid Evidence Generation: Atropos Health enables real-time clinical decision-making through advanced analytics and observational studies.Atropos Health enables real-time clinical decision-making through advanced analytics and observational studies. Emory Pilot Program: Emory is leveraging Atropos Health’s platform to access vast, previously untapped clinical data, enhancing medication formulary design and care protocols.Emory is leveraging Atropos Health’s platform to access vast, previously untapped clinical data, enhancing medication formulary design and care protocols. Real-World Impact: The collaboration aims to directly improve patient care by informing evidence-based treatment strategies.The Atropos Evidence™ Network & Green Button™Unparalleled Data Access: The Atropos Evidence™ Network includes over 300 million patient records, supporting research on both large national datasets and localized Emory data.The Atropos Evidence™ Network includes over 300 million patient records, supporting research on both large national datasets and localized Emory data. Seamless Clinician Support: Emory clinicians can utilize the Green Button™ for immediate access to real-world evidence, using supervised evidence development or the AI-powered ChatRWD® for generating observational study results within minutes.Industry Leadership & InnovationAchieving the Quadruple Aim: “Closing the evidence gap is key to achieving the quadruple aim in healthcare,” said Dr. Brigham Hyde, CEO and co-founder of Atropos Health
What You Should Know:– Arcadia, a healthcare data platform, announced a new AI-driven precision medicine solution designed to identify patients with undiagnosed or misdiagnosed conditions who are at risk of poor health outcomes.– The new AI-enabled solution empowers healthcare providers to connect these patients with appropriate treatments, ultimately improving their health and reducing the total cost of care.AI-Driven Insights for Precision MedicineArcadia launched its precision medicine offering with an initial model developed by Atropos Health, with plans to add more models throughout 2025. This collaboration builds on an existing partnership between the two companies, further integrating Atropos Health’s real-world evidence-generation capabilities into Arcadia’s data platform.Built on Arcadia’s Foundry development platform, the solution allows healthcare providers to:Identify at-risk patients: Leverage AI models to identify patients based on risk factors, demographics, and clinical data.Leverage AI models to identify patients based on risk factors, demographics, and clinical data. Notify care teams: Alert primary care physicians, specialists, and care managers about patients requiring intervention.Alert primary care physicians, specialists, and care managers about patients requiring intervention. Deliver actionable analytics: Integrate insights into existing workflows, such as EHR systems, through SMART-on-FHIR applications.Integrate insights into existing workflows, such as EHR systems, through SMART-on-FHIR applications. Track program effectiveness: Gain insights into the number of patients identified and outcomes achieved through subsequent testing and diagnosis.Strengthened LeadershipArcadia has also bolstered its board of directors with the addition of two experienced healthcare executives:Dr. Scott Ransom: A physician executive with over 30 years of experience in healthcare transformation.A physician executive with over 30 years of experience in healthcare transformation
In May 2024, Atropos Health raised $33 million in funding, with participation from Cencora Ventures, McKesson Ventures, and Merck Global Health Innovation Fund.
What You Should Know:– Atropos Health, a pioneer in real-world evidence (RWE) generation, announced a collaboration with Merck to leverage its innovative platform for rapid insights and analytics from real-world data (RWD).– The strategic partnership will enable Merck’s data science and RWE teams to conduct advanced analyses and generate publication-grade studies in less than 48 hours.– The collaboration follows Atropos Health’s recent launch of ChatRWD™, a groundbreaking generative AI application for rapid RWE generation. In May 2024, the company also secured $33M in funding to advance its AI-driven approach to health data analysis.Accelerating RWE for Life Savings TreatmentsMerck will utilize a suite of Atropos Health’s services, including:GENEVA OS™: A generative evidence acceleration operating system that facilitates rapid cohort creation and advanced analytics.A generative evidence acceleration operating system that facilitates rapid cohort creation and advanced analytics. Green Button™: A tool that simplifies the process of asking clinical questions and generating RWE.A tool that simplifies the process of asking clinical questions and generating RWE. Atropos Evidence™ Network: Access to the industry’s largest federated healthcare data network, with over 300 million patient records.Access to the industry’s largest federated healthcare data network, with over 300 million patient records. Alexandria™: A repository of existing studies that can be rerun on local data to generate novel insights.A repository of existing studies that can be rerun on local data to generate novel insights. Forge™: A low-code research platform for rapid cohort creation and advanced patient studies.A low-code research platform for rapid cohort creation and advanced patient studies